We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

National Survey on Hypertension at Hospital (PROPHYL HO)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00695266
First Posted: June 11, 2008
Last Update Posted: August 6, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AstraZeneca
  Purpose
To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in hospital out patient's department by a cardiologist or a nephrologists.

Condition
Hypertension

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Profile of Hypertensive Patients Seen in Hospital Outpatient's Department

Resource links provided by NLM:


Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Demographic, clinical and health care characteristics [ Time Frame: Once ]

Enrollment: 655
Study Start Date: December 2007
Study Completion Date: September 2008

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
First five consecutive patients with hypertension seen by Cardiologists
Criteria

Inclusion Criteria:

  • Known hypertension
  • agree to take part in this study

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00695266


  Show 120 Study Locations
Sponsors and Collaborators
AstraZeneca
  More Information

Responsible Party: Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00695266     History of Changes
Other Study ID Numbers: NIS-CFR-DUM-2007/5
First Submitted: June 9, 2008
First Posted: June 11, 2008
Last Update Posted: August 6, 2009
Last Verified: August 2009

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases